Loading…
A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer
Schweizer, Michael T., Haugk, Kathleen, McKiernan, Jožefa S., Gulati, Roman, Cheng, Heather H., Maes, Jessica L., Dumpit, Ruth F., Nelson, Peter S., Montgomery, Bruce, McCune, Jeannine S., Plymate, Stephen R., Yu, Evan Y.
Published in PloS one (01.06.2018)
Published in PloS one (01.06.2018)
Get full text
Journal Article
Loading…
Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411)
Schafer, Eric S., Rau, Rachel E., Berg, Stacey L., Liu, Xiaowei, Minard, Charles G., Bishop, Alexander J.R., Romero, J. Carolina, Hicks, M. John, Nelson, Marvin D., Voss, Stephan, Reid, Joel M., Fox, Elizabeth, Weigel, Brenda J., Blaney, Susan M.
Published in Pediatric blood & cancer (01.02.2020)
Published in Pediatric blood & cancer (01.02.2020)
Get full text
Journal Article
Loading…
Loading…
Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin
Kim, Tae Hyung, Shin, Yu Jin, Won, A. Jin, Lee, Byung Mu, Choi, Wahn Soo, Jung, Jee H., Chung, Hae Young, Kim, Hyung Sik
Published in Biochimica et biophysica acta (01.01.2014)
Published in Biochimica et biophysica acta (01.01.2014)
Get full text
Journal Article
Loading…
Pharmacokinetic bioequivalence of the fixed-dose combination of pertuzumab and trastuzumab administered subcutaneously using a handheld syringe or an on-body delivery system
Wynne, Chris, Wang, Bei, Deng, Rong, Li, Junyi, Eiger, Daniel, Bene Tchaleu, Fabiola, Heeson, Sarah, Restuccia, Eleonora
Published in Journal of cancer research and clinical oncology (14.06.2025)
Published in Journal of cancer research and clinical oncology (14.06.2025)
Get full text
Journal Article
Loading…
Model-Informed Immunogenicity Assessment of Nivolumab as Monotherapy and in Combination with Ipilimumab
Zhao, Yue, Li, Li, Ma, Jessica, Roy, Amit, Bello, Akintunde, Sheng, Jennifer, Hamuro, Lora
Published in The AAPS journal (25.04.2025)
Published in The AAPS journal (25.04.2025)
Get full text
Journal Article
Loading…
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors
Becher, Oren J., Gilheeney, Stephen W., Khakoo, Yasmin, Lyden, David C., Haque, Sofia, Braganca, Kevin C., Kolesar, Jill M., Huse, Jason T., Modak, Shakeel, Wexler, Leonard H., Kramer, Kim, Spasojevic, Ivan, Dunkel, Ira J.
Published in Pediatric blood & cancer (01.07.2017)
Published in Pediatric blood & cancer (01.07.2017)
Get full text
Journal Article
Loading…
Population pharmacokinetic and exposure-response analysis to support a dosing regimen of CPX-351 (NS-87) in Japanese adult and pediatric patients with untreated high-risk acute myeloid leukemia
Imai, Shunji, Kitada, Ayane, Ogura, Aya, Akagi, Michiyo, Hasegawa, Mayumi, Vasilinin, Grygoriy, Marier, J.F., Wang, Qi, Ichikawa, Tomohiko, Kusano, Kazutomi
Published in Drug metabolism and pharmacokinetics (01.02.2025)
Published in Drug metabolism and pharmacokinetics (01.02.2025)
Get full text
Journal Article
Loading…
Population Pharmacokinetic Modeling of Certepetide in Human Subjects With Metastatic Pancreatic Ductal Adenocarcinoma
Winning, Alex, Sietsema, William K., Buck, Kristen K., Linsmeier, Abigail, Wiczling, Pawel
Published in Clinical pharmacology in drug development (01.03.2025)
Published in Clinical pharmacology in drug development (01.03.2025)
Get full text
Journal Article
Loading…
Measurement of NLG207 (formerly CRLX101) nanoparticle-bound and released camptothecin in human plasma
Schmidt, Keith T., Peer, Cody J., Huitema, Alwin D.R., Williams, Monique D., Wroblewski, Susan, Schellens, Jan H.M., Madan, Ravi A., Figg, William D.
Published in Journal of pharmaceutical and biomedical analysis (20.03.2020)
Published in Journal of pharmaceutical and biomedical analysis (20.03.2020)
Get full text
Journal Article
Loading…
Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemoimmunotherapy
Monk, Bradley J., Facciabene, Andrea, Brady, William E., Aghajanian, Carol A., Fracasso, Paula M., Walker, Joan L., Lankes, Heather A., Manjarrez, Kristi L., Danet-Desnoyers, Gwenn-äel H., Bell-McGuinn, Katherine M., McCourt, Carolyn K., Malykhin, Alexander, Hershberg, Robert M., Coukos, George
Published in Clinical cancer research (15.04.2017)
Published in Clinical cancer research (15.04.2017)
Get full text
Journal Article
Loading…
A randomized, double-blind, single-dose study (LAVENDER) to assess the safety, tolerability, pharmacokinetics, and immunogenicity of a combined infusion of ABP 980 and pertuzumab in healthy subjects
Hanes, Vladimir, Chow, Vincent, Stewart, Tina, Puri, Adeep
Published in Cancer chemotherapy and pharmacology (01.11.2021)
Published in Cancer chemotherapy and pharmacology (01.11.2021)
Get full text
Journal Article
Loading…
Population pharmacokinetics and exposure–overall survival analysis of the transforming growth factor-β inhibitor galunisertib in patients with pancreatic cancer
Gueorguieva, Ivelina, Tabernero, Josep, Melisi, Davide, Macarulla, Teresa, Merz, Valeria, Waterhouse, Timothy H., Miles, Colin, Lahn, Michael M., Cleverly, Ann, Benhadji, Karim A.
Published in Cancer chemotherapy and pharmacology (01.11.2019)
Published in Cancer chemotherapy and pharmacology (01.11.2019)
Get full text
Journal Article
Loading…
Loading…
Phase I Studies of Sirolimus Alone or in Combination with Pharmacokinetic Modulators in Advanced Cancer Patients
Cohen, Ezra E.W., Wu, Kehua, Hartford, Christine, Kocherginsky, Masha, Eaton, Kimberly Napoli, Zha, Yuanyuan, Nallari, Anitha, Maitland, Michael L., Fox-Kay, Kammi, Moshier, Kristin, House, Larry, Ramirez, Jacqueline, Undevia, Samir D., Fleming, Gini F., Gajewski, Thomas F., Ratain, Mark J.
Published in Clinical cancer research (01.09.2012)
Published in Clinical cancer research (01.09.2012)
Get full text
Journal Article
Loading…
Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial
Lavezzi, Silvia Maria, de Jong, Jan, Neyens, Martine, Cramer, Paula, Demirkan, Fatih, Fraser, Graeme, Bartlett, Nancy, Dilhuydy, Marie-Sarah, Loscertales, Javier, Avigdor, Abraham, Rule, Simon, Samoilova, Olga, Goy, Andre, Ganguly, Siddhartha, Salman, Mariya, Howes, Angela, Mahler, Michelle, De Nicolao, Giuseppe, Poggesi, Italo
Published in Pharmaceutical research (01.07.2019)
Published in Pharmaceutical research (01.07.2019)
Get full text
Journal Article
Loading…
Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic Study
Saba, Nabil F., Hurwitz, Selwyn J., Kono, Scott A., Yang, Chung S., Zhao, Yang, Chen, Zhengjia, Sica, Gabe, Müller, Susan, Moreno-Williams, Rachel, Lewis, Melinda, Grist, William, Chen, Amy Y., Moore, Charles E., Owonikoko, Taofeek K., Ramalingam, Suresh, Beitler, Jonathan J., Nannapaneni, Sreenivas, Shin, Hyung Ju C., Grandis, Jennifer R., Khuri, Fadlo R., Chen, Zhuo Georgia, Shin, Dong M.
Published in Cancer prevention research (Philadelphia, Pa.) (01.03.2014)
Published in Cancer prevention research (Philadelphia, Pa.) (01.03.2014)
Get full text
Journal Article
Loading…
A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia
Redner, Robert L., Beumer, Jan H., Kropf, Patricia, Agha, Mounzer, Boyiadzis, Michael, Dorritie, Kathleen, Farah, Rafic, Hou, Jing-Zhao, Im, Annie, Lim, Seah H., Raptis, Anastasios, Sehgal, Alison, Christner, Susan M., Normolle, Daniel, Johnson, Daniel E.
Published in Leukemia & lymphoma (02.11.2018)
Published in Leukemia & lymphoma (02.11.2018)
Get full text
Journal Article
Loading…
Circadian variation in plasma 5-fluorouracil concentrations during a 24 hour constant-rate infusion
Fleming, Gini F, Schumm, Philip, Friberg, Greg, Ratain, Mark J, Njiaju, Uchenna O, Schilsky, Richard L
Published in BMC cancer (18.02.2015)
Published in BMC cancer (18.02.2015)
Get full text
Journal Article
Loading…
Exposure–response analysis to inform the optimal dose of veliparib in combination with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer patients
Nuthalapati, Silpa, Stodtmann, Sven, Shepherd, Stacie Peacock, Ratajczak, Christine K., Mensing, Sven, Menon, Rajeev, Xiong, Hao
Published in Cancer chemotherapy and pharmacology (01.11.2019)
Published in Cancer chemotherapy and pharmacology (01.11.2019)
Get full text
Journal Article